Onconetix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Onconetix, Inc. (ONCO) on April 30, 2025, covering events occurring on April 24, 2025. The Company is an emerging growth company incorporated in Delaware with principal executive offices in Cincinnati, Ohio. The filing addresses critical compliance issues regarding its listing on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance and listing status rather than financial performance metrics.
Material Changes and Listing Status
The Company faces two distinct delisting risks from Nasdaq:
- Failure to File Annual Report: On April 24, 2025, Nasdaq issued a deficiency notice under Listing Rule 5250(c)(1) due to the Company's failure to timely file its Form 10-K for the fiscal year ended December 31, 2024.
- Minimum Bid Price Violation: The Company previously received notice of non-compliance with the $1.00 minimum bid price requirement (Rule 5550(a)(2)). Subsequently, on April 14, 2025, Nasdaq determined the stock had traded at $0.10 or less for ten consecutive trading days, triggering delisting procedures under Rule 5810(c)(3)(A)(iii).
Trading suspension was stayed pending a hearing before the Nasdaq Hearings Panel, scheduled for May 27, 2025. The Company intends to request a stay of suspension regarding the 10-K filing deficiency by May 1, 2025.
Outlook, Management Commentary, and Risks
Management, represented by Interim CEO and CFO Karina M. Fedasz, stated the Company is working diligently to finalize and file the overdue 10-K on or prior to the May 27, 2025 hearing date. The primary risk is the potential removal of the Company's securities from Nasdaq listing and registration if compliance is not achieved or if the Hearings Panel rules against the Company. A press release disclosing these notices was issued on April 30, 2025.
Investor Verification Checklist
- Verify the status of the Form 10-K for the fiscal year ended December 31, 2024, and confirm if it has been filed.
- Monitor the outcome of the Nasdaq Hearings Panel hearing scheduled for May 27, 2025.
- Confirm whether the Company successfully requests a stay of suspension by the May 1, 2025 deadline.
- Review the Company's current stock price to assess ongoing compliance with minimum bid price rules.